의과대학 - 의과대학

  • 교수 부인암
  • 김민규
CV1

관심분야

자궁내막암,난소암,자궁경부암,유전성 부인암,린치증후군

학력

  • 1991년 3월~1997년 2월:서울대학교 의예과/의학과 :학사
  • 2010년 3월~2012년 2월:성균관대학교 의학과 산부인과 부인종양:석사
  • 2012년 3월~2014년 2월:고려대학교 의학과 산부인과 부인종양:박사

약력/경력

  • 1998년 3월~1999 년 2월 서울대학교 병원 인턴
  • 2003년 3월~2007년 2월 삼성서울병원 산부인과 전공의
  • 2008년 3월~2009년 5월 Sidney Kimmel Cancer Center 연구원,분자생물학,미국,샌디애고
  • 2009년 6월~2011년 8월 삼성서울병원 산부인과 부인종양 전임의
  • 2011년 9월~ 현재 삼성창원병원 산부인과 부인암 조교수/부교수
  • 사단법인 대한부인종양 연구회 이사, 체부암 위원장, 신의료 개발위원회 위원
  • 대한부인종양학회 학술위원, 국제교류위원, 심사위원, 유전성부인암 소위원회 위원
  • 대한산부인과 학회 심사위원, 고시위원, 유전성부인암 소위원회 위원, 의사국가고시 고시위원
  • 대한부인종양학회, 대한부인종양연구회, 대한암학회, 대한종양내과학회, 대한암완화·지지의료연구회 정회원
  • 미국부인암학회 학술위원, 국제교류위원
  • 미국부인암학회(SGO),미국임상암학회(ASCO),미국암연구회(AACR),유럽임상암학회(ESMO) 정회원

학술지 논문

  • (2023)  Initial Experience of Articulating Laparoscopic Instruments for Benign Gynecologic Disease: A Single-Arm Multicenter Prospective Study (Korean Gynecologic Oncology Group 4002).  JOURNAL OF PERSONALIZED MEDICINE.  13,  1433
  • (2022)  Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers.  CANCER RESEARCH AND TREATMENT.  54,  4
  • (2022)  Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test.  CANCERS.  14,  14
  • (2022)  Informed consent forms for gynecologic cancer surgery: recommendations from the Korean Society of Gynecologic Oncology.  JOURNAL OF GYNECOLOGIC ONCOLOGY.  33,  2
  • (2021)  Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers.  CANCERS.  13,  22
  • (2021)  Practice patterns for Lynch syndrome-associated endometrial cancer management in Korea.  EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY.  42,  4
  • (2020)  Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041).  CANCERS.  12,  11
  • (2020)  Performance evaluation of an amplicon-based next-generation sequencing panel forBRCA1andBRCA2variant detection.  JOURNAL OF CLINICAL LABORATORY ANALYSIS.  34,  12
  • (2020)  Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).  EUROPEAN JOURNAL OF CANCER.  56,  65
  • (2019)  Qulaity surveys to compare chemotherapy-induced toxicity and quality of life between two paclitaxel and carboplatin regimens for ovarian carcinoma.  Medical Case REports Journal.  2,  116
  • (2019)  implementation of hereditary gynecologic cancer clinic utilizing existing all screening and geentic methods in community-based hospital by surgeon.  Gynecol Reprod Health.  3,  3
  • (2019)  Clinical Significance of BRCA Gene Testing in Ovarian Carci-noma Patients:Can Advanced Stage Be an Obstacle for Accep-tance of Counseling.  Journal of Clinical and Medical Images.  2,  2
  • (2019)  Emerging Role of Gynecologic Oncologist as BRCA Mutation Counselor for Breast Cancer Patients.  J Womens Health Gyn.  6,  6
  • (2018)  The role of appendectomy in patients with mucinous borderline ovarian tumors.  EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY.  229, 
  • (2018)  The role of appendectomy in patients with mucinous borderline ovarian tumors..  EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY.  229,  229
  • (2017)  Minimally invasive compared with open surgery in patients with borderline ovarian tumors.  GYNECOLOGIC ONCOLOGY.  145,  3
  • (2017)  Practice Patterns of Hereditary Ovarian Cancer Management in Korea.  INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER.  27,  5
  • (2017)  The gate-keeping role of surgeons with regard to endometrial cancers in Lynch syndrome.  JOURNAL OF GYNECOLOGIC ONCOLOGY.  28,  1
  • (2016)  A female adnexal tumor of probable Wolffian origin showing positive O-6-methylguanine-DNA methyltransferase methylation.  Obstetrics & Gynecology Science.  59,  4
  • (2016)  Women with double primary cancers of the colorectum and endometrium: do they have Lynch syndrome?.  EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY.  199, 

단행본

  • (2020)  대한부인종양학회 발간 부인종양학 제 2판.  군자출판사.  공동

수상/공훈

  • 2013 대한부인종양학회 신풍호월 학술상
  • 2017 대한산부인과학회 Best Reviewer (Obstetrics & Gynecology Science)
  • 2018 대한부인종양학회 Best Reviewer (Journal of Gynecologic Oncology)

학술회의논문

  • (2018)  Cancer penetration & interaction of BRCA and MMR mutation.  Hereditary Gynecologic Cancer Symposium.  대한민국
  • (2018)  Lynch syndrome risk evaluation among ovary cancer based on screening methods.  MASCC Annual meeting.  오스트리아
  • (2018)  One case of PARP inhibitor Lynparza®(Olaparib) treatment for A rare BRCA2 and MSH2 mutation recurrent peritoneal cancer.  대한부인종양학회 2018 춘계학술대회.  대한민국
  • (2018)  Patient's choice about variable genomic test vendors beyond country border:One mutated BRCA mutation result of ovary cancer patient.  대한부인종양학회 2018 춘계학술대회.  대한민국
  • (2016)  유전성자궁암환자 대처하기.  대한부인종양연구회 KGOG meeting.  대한민국
  • (2016)  Selective screening among endometrial cancer for Lynch syndrome: single surgeon experience.  2016 대한암학회 Annual meeting.  대한민국
  • (2016)  Practical approach & issue for Lynch syndrome.  2016 대한부인종양학회 Annual meeting.  대한민국
  • (2015)  Clinical significance of BRCA testing and genetic counseling in Advanced stage ovarian carcinoma.  4th Biennial Meeting of Asian Society of Gynecologic Oncology.  대한민국
  • (2015)  Early detection of hereditary cancer syndrome patients through surgeon's counseling among endometrial and ovary carcinoma.  53rd Annual Meeting of Japan Society of Clinical Oncology(JSCO).  일본
  • (2015)  Impact of early genetic counseling about BRCA mutation on ovary carcinoma patients by surgeon.  2015 일본산부인과 Annual meeting.  일본
  • (2014)  Importance of genetic counseling by surgeon regarding BRCA mutation for ovary carcinoma patients:single surgeon study in korea.  Cell symposium(Hallmarks of Cancer:Asia).  중국
  • (2014)  Genetic cancer incidence among ovary carcinoma patients based on active genetic counseling and immunohistochemistry.  미국암학회 (AACR).  미국
  • (2014)  Cervical adenocarcinoma in situ with coexisting squamous cell lesions : Impact on recurrence.  미국부인종양학회 연례학회(SGO annual meeting).  미국
  • (2013)  Active genetic counseling with immunohistochemistry can elevate detection rate of BRCA mutation among ovarian carcinoma patient.  The 3rd Biennial Meeting of Asian Society of Gynecologic Oncology.  일본
  • (2013)  Genetic risk evaluation by immunohistochemistry in premalignant endometrial lesions.  JAPAN CANCER ASSOCIATION 2013 ANNUAL MEETING.  일본
  • (2013)  Frequency of Lynch syndrome and HBOC(Hereditary breast and ovary cancer) among gynecologic malignancy.  JAPAN CANCER ASSOCIATION 2013 ANNUAL MEETING,YOKOHAMA.  일본
  • (2013)  Successful rate of genetic counseling and tests for gynecologic malignancy in Korea.  대한암학회 39회 학술대회.  대한민국
  • (2012)  Importance of screening regarding lynch syndrome in endometrial cancer patients without family history.  14th Biennial Meeting of the International Gynecologic Cancer Society.  캐나다
  • (2012)  Chance of Hereditary Risk with Sequential Endometrial and Colon cancer with regard to Lynch syndrome: A pilot study.  2012 British Gynaecological Cancer Society Annual Scientific Meeting.  영국

Movie